rs114903768
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2
The NM_005076.5(CNTN2):c.1516C>A(p.Arg506Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00205 in 1,613,922 control chromosomes in the GnomAD database, including 67 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.011 ( 35 hom., cov: 32)
Exomes 𝑓: 0.0011 ( 32 hom. )
Consequence
CNTN2
NM_005076.5 synonymous
NM_005076.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.81
Publications
2 publications found
Genes affected
CNTN2 (HGNC:2172): (contactin 2) This gene encodes a member of the contactin family of proteins, part of the immunoglobulin superfamily of cell adhesion molecules. The encoded glycosylphosphatidylinositol (GPI)-anchored neuronal membrane protein plays a role in the proliferation, migration, and axon guidance of neurons of the developing cerebellum. A mutation in this gene may be associated with adult myoclonic epilepsy. [provided by RefSeq, Sep 2016]
CNTN2 Gene-Disease associations (from GenCC):
- complex neurodevelopmental disorderInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- epilepsy, familial adult myoclonic, 5Inheritance: AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- benign adult familial myoclonic epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.19).
BP6
Variant 1-205064747-C-A is Benign according to our data. Variant chr1-205064747-C-A is described in ClinVar as Benign. ClinVar VariationId is 474465.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.81 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0114 (1739/152322) while in subpopulation AFR AF = 0.0397 (1651/41558). AF 95% confidence interval is 0.0381. There are 35 homozygotes in GnomAd4. There are 819 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 35 AR,AD gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CNTN2 | NM_005076.5 | c.1516C>A | p.Arg506Arg | synonymous_variant | Exon 12 of 23 | ENST00000331830.7 | NP_005067.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CNTN2 | ENST00000331830.7 | c.1516C>A | p.Arg506Arg | synonymous_variant | Exon 12 of 23 | 1 | NM_005076.5 | ENSP00000330633.4 |
Frequencies
GnomAD3 genomes AF: 0.0114 AC: 1735AN: 152204Hom.: 35 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
1735
AN:
152204
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00292 AC: 722AN: 247468 AF XY: 0.00220 show subpopulations
GnomAD2 exomes
AF:
AC:
722
AN:
247468
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00108 AC: 1574AN: 1461600Hom.: 32 Cov.: 32 AF XY: 0.000932 AC XY: 678AN XY: 727088 show subpopulations
GnomAD4 exome
AF:
AC:
1574
AN:
1461600
Hom.:
Cov.:
32
AF XY:
AC XY:
678
AN XY:
727088
show subpopulations
African (AFR)
AF:
AC:
1340
AN:
33480
American (AMR)
AF:
AC:
74
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26132
East Asian (EAS)
AF:
AC:
0
AN:
39696
South Asian (SAS)
AF:
AC:
6
AN:
86246
European-Finnish (FIN)
AF:
AC:
0
AN:
53250
Middle Eastern (MID)
AF:
AC:
6
AN:
5766
European-Non Finnish (NFE)
AF:
AC:
18
AN:
1111930
Other (OTH)
AF:
AC:
130
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
86
171
257
342
428
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0114 AC: 1739AN: 152322Hom.: 35 Cov.: 32 AF XY: 0.0110 AC XY: 819AN XY: 74470 show subpopulations
GnomAD4 genome
AF:
AC:
1739
AN:
152322
Hom.:
Cov.:
32
AF XY:
AC XY:
819
AN XY:
74470
show subpopulations
African (AFR)
AF:
AC:
1651
AN:
41558
American (AMR)
AF:
AC:
59
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5180
South Asian (SAS)
AF:
AC:
1
AN:
4832
European-Finnish (FIN)
AF:
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
AC:
6
AN:
68036
Other (OTH)
AF:
AC:
21
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
83
167
250
334
417
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
4
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Epilepsy, familial adult myoclonic, 5 Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.